Cornercap Investment Counsel Inc. Takes Position in Cardinal Health, Inc. $CAH

Posted by Stanley Muller on Jun 13th, 2026

Cornercap Investment Counsel Inc. bought a new stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 8,289 shares of the company’s stock, valued at approximately $1,703,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Norges Bank acquired a new position in Cardinal Health during the 4th quarter worth about $790,344,000. Wellington Management Group LLP lifted its position in Cardinal Health by 153.2% during the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares in the last quarter. Holocene Advisors LP lifted its position in Cardinal Health by 141.4% during the 3rd quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after buying an additional 1,128,358 shares in the last quarter. Barclays PLC lifted its position in Cardinal Health by 109.3% during the 3rd quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock worth $248,658,000 after buying an additional 827,446 shares in the last quarter. Finally, SG Americas Securities LLC lifted its position in Cardinal Health by 3,829.1% during the 4th quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock worth $149,504,000 after buying an additional 708,995 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Up 1.2%

Cardinal Health stock opened at $223.76 on Friday. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $233.60. The company has a market cap of $52.41 billion, a PE ratio of 34.21, a PEG ratio of 1.21 and a beta of 0.52. The company’s 50-day moving average is $203.21 and its two-hundred day moving average is $208.85.

Cardinal Health (NYSE:CAH – Get Free Report) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same period in the prior year, the company posted $2.35 EPS. The company’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Wednesday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is currently 31.19%.

Analysts Set New Price Targets

CAH has been the topic of several research reports. JPMorgan Chase & Co. reduced their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. Evercore reduced their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Barclays upped their price target on shares of Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. Morgan Stanley upped their price target on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. Finally, Weiss Ratings downgraded shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $246.93.

Get Our Latest Analysis on Cardinal Health

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.